Skip to content

Drug interactions

Etrasimod + Regorafenib

Severity: Moderate

Etrasimod and Regorafenib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Etrasimod reduces circulating lymphocytes and regorafenib is an antineoplastic with potential myelosuppressive and infection-related effects. Together they may increase infection risk, though combined use has not been formally studied.

What this interaction means in plain words

Etrasimod and Regorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Etrasimod belongs to Gastrointestinal Tract; Regorafenib belongs to Oncology.

Evidence level: Low

Why it happens

Additive immunosuppression from S1P receptor modulation-related lymphocyte sequestration and antineoplastic effects.

What to do

Monitor for signs of infection and check blood counts. Consider whether etrasimod is needed during cancer therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Etrasimod and Regorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Etrasimod with Regorafenib?

MediHelp rates the interaction as moderate. Etrasimod and Regorafenib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Etrasimod reduces circulating lymphocytes and regorafenib is an antineoplastic with potential myelosuppressive and infection-related effects. Together they may increase infection risk, though combined use has not been formally studied.

How serious is the interaction between Etrasimod and Regorafenib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of infection and check blood counts. Consider whether etrasimod is needed during cancer therapy.

What other medicines interact with Regorafenib?

MediHelp also lists interactions of Regorafenib with, for example, Apalutamide, Atazanavir, Carbamazepine. The full list is on the Regorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in